ES2082212T3 - Nuevos inhibidores de alfa-glucosidasa. - Google Patents

Nuevos inhibidores de alfa-glucosidasa.

Info

Publication number
ES2082212T3
ES2082212T3 ES91912140T ES91912140T ES2082212T3 ES 2082212 T3 ES2082212 T3 ES 2082212T3 ES 91912140 T ES91912140 T ES 91912140T ES 91912140 T ES91912140 T ES 91912140T ES 2082212 T3 ES2082212 T3 ES 2082212T3
Authority
ES
Spain
Prior art keywords
glucosidase inhibitors
new alpha
alpha
new
polyglycosidyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912140T
Other languages
English (en)
Inventor
Jean-Bernard Ducep
Charles Danzin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2082212T3 publication Critical patent/ES2082212T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTE INVENTO MUESTRA NUEVOS DERIVADOS DE POLIGLICOSIDILO DE 1 DEOXI PLICACIONES FINALES, ESPECIALMENTE SU USO EN EL TRATAMIENTO DE DIABETES.
ES91912140T 1990-06-08 1991-05-17 Nuevos inhibidores de alfa-glucosidasa. Expired - Lifetime ES2082212T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90401582 1990-06-08

Publications (1)

Publication Number Publication Date
ES2082212T3 true ES2082212T3 (es) 1996-03-16

Family

ID=8205720

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91912140T Expired - Lifetime ES2082212T3 (es) 1990-06-08 1991-05-17 Nuevos inhibidores de alfa-glucosidasa.

Country Status (7)

Country Link
EP (1) EP0532668B1 (es)
JP (1) JP3136491B2 (es)
AT (1) ATE130304T1 (es)
AU (1) AU8069891A (es)
DE (1) DE69114707T2 (es)
ES (1) ES2082212T3 (es)
WO (1) WO1991018915A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
AU7083594A (en) * 1993-07-02 1995-01-24 Nippon Shinyaku Co. Ltd. Galactosylmoranoline derivative
WO1995006057A1 (fr) * 1993-08-23 1995-03-02 Nippon Shinyaku Co., Ltd. Derive de galactosylmoraniline
US5633233A (en) * 1995-06-07 1997-05-27 Alberta Research Council Modified kojibiosides analogues
US20060025449A1 (en) * 2004-03-25 2006-02-02 United Therapeutics Use of N-substituted imino sugars for appetite suppression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6055078B2 (ja) * 1980-12-01 1985-12-03 日本新薬株式会社 モラノリンの誘導体
GB2181729B (en) * 1985-10-12 1990-04-04 Nippon Shinyaku Co Ltd Glucosylmoranoline derivatives and production thereof
JPS62242692A (ja) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd モラノリン誘導体の製造法
JP2504000B2 (ja) * 1986-09-02 1996-06-05 日本新薬株式会社 グルコシルモラノリン誘導体

Also Published As

Publication number Publication date
EP0532668A1 (en) 1993-03-24
AU8069891A (en) 1991-12-31
EP0532668B1 (en) 1995-11-15
JP3136491B2 (ja) 2001-02-19
JPH05509082A (ja) 1993-12-16
DE69114707D1 (de) 1995-12-21
DE69114707T2 (de) 1996-06-13
ATE130304T1 (de) 1995-12-15
WO1991018915A1 (en) 1991-12-12

Similar Documents

Publication Publication Date Title
TR200200068T2 (tr) Nematisital triflüorobütenler
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DK15589A (da) Kemiske forbindelser
IE891798L (en) Novel ó-glucosidase inhibitors
FI840748A (fi) Kinolonkarbonsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella aemnen.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
DE69109401T2 (de) Wässrige Zusammensetzungen zur Behandlung von porösen Substraten.
DE69113221T2 (de) Antiatherosclerotische und antithrombotische 2-amino-6-phenyl-4h-pyran-4-one.
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
MY120530A (en) Combination preparation for use in dementia
ATE281165T1 (de) Verwendung von pramipexol zur behandlung von restless-legs-syndrom
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
FI870873A0 (fi) Isohexid-nukleosid.
DE58909244D1 (de) Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht.
UA26438A (uk) СПОСІБ ОТРИМАHHЯ СУЛЬФОHІЛФЕHІЛ- БЕttА-D-ТІОКСИЛОЗИДІВ
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
SE9001111D0 (sv) Supportive use
ES2085937T3 (es) Desacilacion enzimatica de acil-aminosorbosas y su uso en la fabricacion de 1-desoxinoyirimicina.
ES2016857B3 (es) Derivados de 4 - feniltiazol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 532668

Country of ref document: ES